Announcements Trials
Browse Landscape

Phase

Phase 3 6Phase 2 6Phase NA 4Phase 2/3 1

Status

Unknown 4

Sponsor Class

OTHER 3OTHER_GOV 1

Study Type

Interventional 4

Sponsor

Cancer Type

Thoracic 4

Conditions

Breast Neoplasms 3856Neoplasms 2988Prostatic Neoplasms 1751Colorectal Neoplasms 1426Lung Neoplasms 1328Motor Activity 802Head and Neck Neoplasms 683Pancreatic Neoplasms 663Colonic Neoplasms 655Uterine Cervical Neoplasms 648Carcinoma, Non-Small-Cell Lung 629Carcinoma, Hepatocellular 628Rectal Neoplasms 569Stomach Neoplasms 544Brain Neoplasms 483Ovarian Neoplasms 438Anxiety Disorders 419Pain 418Neoplasm Metastasis 385Esophageal Neoplasms 384Polycystic Ovary Syndrome 374Precursor Cell Lymphoblastic Leukemia-Lymphoma 354Urinary Bladder Neoplasms 351Fatigue 339Melanoma 322Multiple Myeloma 321Lymphoma 305Depression 305Endometrial Neoplasms 289Liver Neoplasms 279

Interventions

anlotinib 3Pemetrexed 2endostar protein 1Gefitinib 1Docetaxel 1Cisplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase NA × Non-squamous Non-small Cell Lung Cancer × Clear all
NCT04063449 2019-08-21

Endostar/PD-1 Inhibitors Combined With PP for Advanced NSCLC

Third Military Medical University

Phase NA Unknown
170 enrolled
Thoracic

Non-squamous Non-small Cell Lung Cancer

NCT03671538 2018-09-17

Non Squamous NSCLC Patients With Anlotinib Combined With Pemetrexed and Cisplatin

The First Affiliated Hospital of Nanchang University

Phase NA Unknown
62 enrolled
Thoracic

Non-squamous Non-small Cell Lung Cancer

NCT03602027 2018-07-26

Phase I Study of the Combination of Anlotinib With Gefitinib

Second Affiliated Hospital of Nanchang University

Phase NA Unknown
9 enrolled
Thoracic

Non-squamous Non-small Cell Lung Cancer

NCT03566576 2018-06-25

Phase I Study of the Combination of Anlotinib With Pemetrexed or Docetaxel

Fujian Cancer Hospital

Phase NA Unknown
18 enrolled
Thoracic

Non-squamous Non-small Cell Lung Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡